Helius Medical Technologies, Inc. (HSDT)

HSDT Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	3	6	9	12	20	25
Market Cap Growth	-28.04%	-34.22%	-30.33%	-36.47%	-22.18%	-88.27%
Enterprise Value	-1	1	-6	1	16	20
PE Ratio	-	-0.64	-0.61	-0.68	-1.38	-2.57
PS Ratio	4.28	8.84	11.00	23.80	29.58	16.80
PB Ratio	1.44	2.42	1.06	1.10	5.05	4.31
P/FCF Ratio	-0.51	-0.55	-0.60	-0.92	-1.66	-1.18
P/OCF Ratio	-0.51	-0.55	-0.60	-0.93	-1.67	-1.20
EV/Sales Ratio	2.37	0.88	-7.35	2.72	24.68	13.57
EV/EBITDA Ratio	-0.18	-0.06	0.45	-0.08	-1.22	-2.12
EV/EBIT Ratio	-0.18	-0.06	0.44	-0.08	-1.15	-2.08
EV/FCF Ratio	-0.15	-0.05	0.40	-0.11	-1.39	-0.95
Debt / Equity Ratio	0.02	0.02	0.01	0.00	0.02	0.11
Debt / EBITDA Ratio	-0.01	-0.01	-0.01	0.00	-0.01	-0.07
Debt / FCF Ratio	0.00	-0.01	-0.01	0.00	-0.01	-0.03
Quick Ratio	2.66	3.10	7.49	4.24	1.47	1.59
Current Ratio	3.51	3.96	8.40	4.75	1.93	1.91
Asset Turnover	0.08	0.06	0.06	0.04	0.09	0.09
Interest Coverage	-	-	-15.87	-	-	-
Return on Equity (ROE)	-297.50%	-221.10%	-171.90%	-198.40%	-302.70%	-99.20%
Return on Assets (ROA)	-107.40%	-86.20%	-107.60%	-153.10%	-190.10%	-61.20%
Return on Capital (ROIC)	-592.22%	-516.33%	-187.82%	-161.13%	-363.10%	-370.77%
Earnings Yield	-310.27%	-155.43%	-162.58%	-145.96%	-72.26%	-38.93%
FCF Yield	-358.18%	-183.45%	-165.45%	-108.22%	-60.07%	-84.98%
Buyback Yield / Dilution	-44.88%	-125.20%	-449.35%	-105.12%	-59.07%	-15.65%
Total Shareholder Return	-44.88%	-125.20%	-449.35%	-105.12%	-59.07%	-15.65%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).